Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AUROBINDO PHARMA

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 34
  • 0 comments

FDA approve PRAVASTATIN SODIUM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 34
  • 0 comments

FDA approve ROFLUMILAST

Comment Full text

ABBVIE ENDOCRINE INC

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve LEUPROLIDE ACETATE

Comment Full text

PADAGIS ISRAEL

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve BUDESONIDE

Comment Full text

ACCORD HLTHCARE

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 35
  • 0 comments

FDA approve PRASUGREL HYDROCHLORIDE

Comment Full text

HOSPIRA

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 33
  • 0 comments

FDA approve KETAMINE HYDROCHLORIDE

Comment Full text

AJANTA PHARMA LTD

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 33
  • 0 comments

FDA approve VENLAFAXINE HYDROCHLORIDE

Comment Full text

AKORN

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve LOTEPREDNOL ETABONATE

Comment Full text

APPCO

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve VALGANCICLOVIR HYDROCHLORIDE

Comment Full text

TORRENT

  • FDA Approval
  • April 17, 2023, 11:41 UTC
  • 32
  • 0 comments

FDA approve SORAFENIB TOSYLATE

Comment Full text
  • Previous
  • 841
  • 842
  • 843
  • 844
  • 845
  • Next

Search

News categories

  • Technical Exchange News(14775)
  • Event(6229)
  • SEC News(398991)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(243084)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin